<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-pharmaceuticals-14-00381">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fu</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Why tocilizumab could be an effective treatment for severe COVID-19?</article-title>
  <source>J. Transl. Med.</source>
  <year>2020</year>
  <volume>18</volume>
  <fpage>164</fpage>
  <pub-id pub-id-type="doi">10.1186/s12967-020-02339-3</pub-id>
  <pub-id pub-id-type="pmid">32290839</pub-id>
 </element-citation>
</ref>
